References
Deng Y, Chang C, Lu Q (2016) The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol 50(3):377–389. https://doi.org/10.1007/s12016-016-8535-x
Hirahara K, Nakayama T (2016) CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol 28(4):163–171. https://doi.org/10.1093/intimm/dxw006
Millán-Pascual J, Turpín-Fenoll L, Del Saz-Saucedo P, Rueda-Medina I, Navarro-Muñoz S (2012) Psoriasis during natalizumab treatment for multiple sclerosis. J Neurol 259(12):2758–2760. https://doi.org/10.1007/s00415-012-6713-1
Park SJ, Im DS (2017) Sphingosine 1-phosphate receptor modulators and drug discovery. Biomol Ther (Seoul) 25(1):80–90. https://doi.org/10.4062/biomolther.2016.160
Ishii M (2017) Immunology proves a great success for treating autoimmune diseases—a perspective on immunopharmacology: IUPHAR Review 23. Br J Pharmacol 2017 Jul;174(13):1875–1880. doi: https://doi.org/10.1111/bph.13784
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr Veria Vacchiano is involved in clinical trials sponsored by Roche and Biogen. She received travel grants from Genzyme/Sanofi.
Dr Matteo Foschi is involved in a clinical trial sponsored by Roche and Biogen. He received travel grants from Biogen and Genzyme/Sanofi.
Dr Loredana Sabattini is involved in a clinical trial sponsored by Roche and received travel grants from Teva, Almirall, and Biogen.
Dr Cinzia Scandellari received compensation for Advisory Board activities from Genzyme/Sanofi and travel grants from Genzyme/Sanofi, Teva, Merck, and Novartis. Her institution (IRCCS) received research grants from Merck, Novartis Pharma, Roche, and Biogen.
Prof Alessandra Lugaresi has served as a Bayer, Biogen, Genzyme/Sanofi, Merck Serono, Novartis, and Teva Advisory Board Member. She received travel grants and honoraria from Bayer, Biogen, Genzyme, Merck Serono, Novartis, Sanofi, and Teva and her institution received research grants from Almirall, Bayer, Biogen, Merck Serono, Novartis, Sanofi, and Teva. Prof Lugaresi has also received travel and research grants from the Associazione Italiana Sclerosi Multipla.
Rights and permissions
About this article
Cite this article
Vacchiano, V., Foschi, M., Sabattini, L. et al. Arthritic psoriasis during natalizumab treatment: a case report and review of the literature. Neurol Sci 39, 181–183 (2018). https://doi.org/10.1007/s10072-017-3112-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-3112-5